Contract Deobligations Alert — September 09, 2026

The $110.6 million firm-fixed-price delivery order for low-energy non-intrusive inspection systems is 84% outlayed ($92.8M), indicating robust cash flow and contract execution. Performance extends to 2027 with potential to 2033, providing long-term revenue visibility for Astrophysics Inc.

The $107.4 million firm-fixed-price contract for an Employee Assistance Program (2014-2022) was awarded non-competitively, but only $13.2 million is outlayed (12.3%), suggesting low current cash flow. The fixed-price structure and non-competitive award introduce execution and pricing risk.

Astrophysics Inc.'s $110.6M contract is firm-fixed-price, carrying execution risk over a long performance period (2027-2033). Any cost overruns or performance failures could compress margins.

Magellan Healthcare Inc. has a $107.4M contract with only 12.3% outlayed, indicating potential revenue concentration risk if the contract is not fully utilized or is recompeted. The non-competitive award also raises questions about competitive dynamics.

Astrophysics Inc.'s $110.6M DHS contract highlights growth in border security inspection technology, a stable civilian sector. The long performance period and potential extension to 2033 offer a multi-year revenue runway.

Magellan Healthcare Inc.'s non-competitive $107.4M HHS contract suggests a strong incumbent position in employee assistance programs. If recompeted, the sole-source history could indicate a competitive moat, but also invites protest risk.

The $110.6M Astrophysics Inc. contract for non-intrusive inspection systems demonstrates sustained DHS/CBP investment in advanced detection technologies, a niche but stable civilian sector.

The $107.4M Magellan Healthcare Inc. contract, awarded non-competitively, reflects a trend in HHS sole-source awards for specialized human resources and managed healthcare services, reducing competitive pressure but increasing regulatory scrutiny.

{"entity" => "Astrophysics Inc.", "reason" => "The $110.6M DHS contract is 84% outlayed, signaling strong execution, but the firm-fixed-price structure and long performance period warrant monitoring for margin pressure.", "trigger" => "DHS/CBP budget allocation announcements, contract modification filings, option exercise dates"}

{"entity" => "Magellan Healthcare Inc.", "reason" => "The $107.4M HHS contract has low outlay (12.3%) and a 2022 end date, creating uncertainty about future revenue. Non-competitive award dynamics could shift.", "trigger" => "Recompetition announcement, contract extension filing, HHS budget for employee assistance programs"}